Molly Henderson's Net Worth
Molly Henderson's net worth is estimated to be at least $467,445.06 as of 02/24/2025. CoreStreet's estimation of Molly Henderson's net worth is based on their sale of stock and current holding of stock.
Molly Henderson is CFO at Phathom Pharmaceuticals Inc. They have executed at least 13 trades of stock as per SEC Form 4 filings. Their most recent trade was for 6,583 units of PHAT stock on 01/21/2025. Their biggest sale was on 11/01/2023 when they sold 12,492 units of Phathom Pharmaceuticals Inc stock for $110,928.96. They typically trade 2 times per year.
Total value of insider buys:
- $39,625.00
Total value of insider sells:
- $427,820.06
Most recent insider trade:
- Jan. 21, 2025
Molly Henderson's Insider Trading History
| Phathom Pharmaceuticals Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Jan. 21, 2025 | CFO | 6,583 | $6.59 | Sell | $43,381.97 |
Dec. 19, 2024 | CFO | 1,291 | $8.00 | Sell | $10,328.00 |
July 15, 2024 | CFO | 4,325 | $11.72 | Sell | $50,689.00 |
April 8, 2024 | CFO | 3,435 | $11.10 | Sell | $38,128.50 |
Jan. 19, 2024 | CFO | 6,307 | $7.75 | Sell | $48,879.25 |
Nov. 1, 2023 | CFO | 12,492 | $8.88 | Sell | $110,928.96 |
June 2, 2023 | CFO | 1,960 | $11.41 | Sell | $22,363.60 |
May 22, 2023 | CFO | 2,110 | $12.87 | Sell | $27,155.70 |
April 6, 2023 | CFO | 3,439 | $7.27 | Sell | $25,001.53 |
March 1, 2023 | CFO | 2,032 | $8.53 | Sell | $17,332.96 |
| UroGen Pharma Ltd | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Jan. 31, 2022 | CFO | 331 | $7.58 | Sell | $2,508.98 |
Nov. 30, 2021 | CFO | 2,587 | $12.03 | Sell | $31,121.61 |
May 17, 2021 | CFO | 2,500 | $15.85 | Buy | $39,625.00 |